Pharmaceuticals

Fighting Diseases

Latest News
October 05, 2022
Bayer completes sale of its Environmental Science Professional business to Cinven
September 26, 2022
Not intended for U.S. and UK Media
Eylea® approved in Japan for treatment of preterm infants with retinopathy of prematurity
September 20, 2022
Not intended for U.S. and UK Media - EASD Congress 2022:
Bayer to present new cardiorenal data for Kerendia™ (finerenone) across a broad range of patients with early to late-stage chronic kidney disease and type 2 diabetes